Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
Withdrawn before enrolling · Not applicable
Conditions studied: Obsessive-Compulsive Disorder
In brief
The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for obsessive compulsive disorder (OCD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in Y-BOCS scores than those in the waitlist condition at treatment endpoint (week 12).
Key facts
- Study ID
- NCT03767491
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2019-07-01
- Expected to finish
- 2022-06-01
- Last updated by the study team
- 2022-08-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- at least 18 years of age
- current diagnosis of primary DSM-5 OCD, based on MINI
- currently living in the United States
You may not qualify if…
- Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
- Past participation in ≥ 4 sessions of CBT for OCD
- Current severe substance use disorder
- Lifetime bipolar disorder or psychosis
- Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥ 2 on the suicidal ideation subscale of the C-SSRS
- Current severe comorbid major depression, as indicated by clinical judgment and/or a QIDS-SR total score ≥ 21
- Concurrent psychological treatment
- Does not own a supported mobile Smartphone with a data plan
- Lack of technology literacy that would interfere with ability to engage with smartphone treatment
Where it is running
- Anna Schwartzberg — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.